Anning Zuo

501 total citations · 1 hit paper
23 papers, 216 citations indexed

About

Anning Zuo is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Anning Zuo has authored 23 papers receiving a total of 216 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Anning Zuo's work include Cancer Cells and Metastasis (6 papers), Immune cells in cancer (5 papers) and Immunotherapy and Immune Responses (4 papers). Anning Zuo is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Immune cells in cancer (5 papers) and Immunotherapy and Immune Responses (4 papers). Anning Zuo collaborates with scholars based in China, United Kingdom and Ireland. Anning Zuo's co-authors include Yuhao Ba, Xinwei Han, Zaoqu Liu, Shutong Liu, Quan Cheng, Yuqing Ren, Siyuan Weng, Peng Luo, Yuyuan Zhang and Hui Xu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Anning Zuo

19 papers receiving 213 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multi-stage mechanisms of tumor metastasis and therapeutic strategies

2024 54 citations Zaoqu Liu, Jingqi Chen et al. Signal Transduction and Targeted Therapy profile →

Peers

Anning Zuo

ONCOL

IMMUN

PRM

Fateme Sheida Iran

Ye’ela Scharff Israel

Andrea Z. Tuckett United States

Vanessa Klapp United States

Ellen Brenner Germany

Yael Zait Israel

Daniel Dávila‐González United States

Yaoxu Chen China

Ryan C. Augustin United States

Anouchka Coste United States

Fateme Sheida Iran

Anning Zuo

51 ×0.5

ONCOL

28 ×0.4

IMMUN

56 ×0.9

23 ×0.7

PRM

35 ×1.2

Citations per year, relative to Anning Zuo Anning Zuo (= 1×) peers Fateme Sheida

Countries citing papers authored by Anning Zuo

Since Specialization

Citations

This map shows the geographic impact of Anning Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anning Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anning Zuo more than expected).

Fields of papers citing papers by Anning Zuo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anning Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anning Zuo. The network helps show where Anning Zuo may publish in the future.

Co-authorship network of co-authors of Anning Zuo

This figure shows the co-authorship network connecting the top 25 collaborators of Anning Zuo. A scholar is included among the top collaborators of Anning Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anning Zuo. Anning Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Zaoqu, Yuhao Ba, Dan Shan, et al.. (2025). THBS2-producing matrix CAFs promote colorectal cancer progression and link to poor prognosis via the CD47-MAPK axis. Cell Reports. 44(4). 115555–115555. 4 indexed citations

Ren, Yuqing, Congying Yuan, Yuhao Ba, et al.. (2025). 3D Bioprinting for Engineering Organoids and Organ‐on‐a‐Chip: Developments and Applications. Medicinal Research Reviews. 45(6). 1630–1650. 5 indexed citations

Ren, Yuqing, Anning Zuo, Shutong Liu, et al.. (2025). Cancer-associated fibroblasts drive lung adenocarcinoma progression via THBS2-mediated epithelial-mesenchymal transition. Oncogene. 44(44). 4284–4297.

Liu, Shutong, Mei Kang, Yuqing Ren, et al.. (2025). The Interaction Between Vasculogenic Mimicry and the Immune System: Mechanistic Insights and Dual Exploration in Cancer Therapy. Cell Proliferation. 58(6). e13814–e13814. 5 indexed citations

Shan, Dan, Yuqing Ren, Yuyuan Zhang, et al.. (2025). Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities. Cancer Communications. 45(5). 577–607. 5 indexed citations

Liu, Zaoqu, Yuqing Ren, Jingqi Chen, et al.. (2025). Efferocytosis: The Janus‐Faced Gatekeeper of Aging and Tumor Fate. Aging Cell. 24(2). e14467–e14467. 3 indexed citations

Wang, Ruizhi, Yudi Xu, Yuyuan Zhang, et al.. (2025). Total and regional fat-to-muscle mass ratio and risks of pan-cancer: a prospective cohort study. BMC Medicine. 23(1). 296–296. 1 indexed citations

Pan, Teng, Yuyuan Zhang, Yushuai Wu, et al.. (2025). Cancer-associated fibroblasts enhance colorectal cancer lymphatic metastasis via CLEC11A/LGR5-mediated WNT pathway activation. Journal of Clinical Investigation. 135(20).

Lv, Ying-ying, Zhongxin Li, Zhaokai Zhou, et al.. (2025). Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy. Molecular Cancer. 24(1). 210–210. 9 indexed citations

10.

Liu, Long, Siying Zhang, Yuqing Ren, et al.. (2025). Macrophage-derived exosomes in cancer: a double-edged sword with therapeutic potential. Journal of Nanobiotechnology. 23(1). 319–319. 6 indexed citations

11.

Dang, Qin, Zhaokai Zhou, Shuang Chen, et al.. (2024). Molecular subtypes of colorectal cancer in the era of precision oncotherapy: Current inspirations and future challenges. Cancer Medicine. 13(14). e70041–e70041. 5 indexed citations

12.

Zhou, Zhaokai, Jiaxin Xu, Shutong Liu, et al.. (2024). Infiltrating treg reprogramming in the tumor immune microenvironment and its optimization for immunotherapy. Biomarker Research. 12(1). 97–97. 15 indexed citations

13.

Zhou, Zhaokai, Yifeng Chen, Yuhao Ba, et al.. (2024). Revolutionising Cancer Immunotherapy: Advancements and Prospects in Non‐Viral CAR‐NK Cell Engineering. Cell Proliferation. 58(4). e13791–e13791. 10 indexed citations

14.

Liu, Zaoqu, Jingqi Chen, Yuqing Ren, et al.. (2024). Multi-stage mechanisms of tumor metastasis and therapeutic strategies. Signal Transduction and Targeted Therapy. 9(1). 270–270. 54 indexed citations breakdown →

15.

Liu, Zaoqu, Zhaokai Zhou, Yuhao Ba, et al.. (2024). Targeting immunosenescence for improved tumor immunotherapy. SHILAP Revista de lepidopterología. 5(11). e777–e777. 13 indexed citations

16.

Zuo, Anning, Siyuan Weng, Hui Xu, et al.. (2024). Integrated Exploration of Epigenetic Dysregulation Reveals a Stemness/EMT Subtype and MMP12 Linked to the Progression and Prognosis in Hepatocellular Carcinoma. Journal of Proteome Research. 23(5). 1821–1833. 3 indexed citations

17.

Zhang, Yuyuan, Yuqing Ren, Yuhao Ba, et al.. (2024). Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application. Molecular Cancer. 23(1). 75–75. 38 indexed citations

18.

Zuo, Anning, Wenlong Jia, Yuhao Ba, et al.. (2024). High ratio of resident to exhausted CD4 + T cells predicts favorable prognosis and potentially better immunotherapeutic efficacy in hepatocellular carcinoma. BMC Cancer. 24(1). 1152–1152.

19.

Zhou, Xing, Jiashu Han, Anning Zuo, et al.. (2024). THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancer. Molecular Cancer. 23(1). 282–282. 25 indexed citations

20.

Chen, Zhuang, Yuhao Ba, Qin Dang, et al.. (2023). MPDZ is associated with immune infiltration and regulates migration and invasion by switching YAP1 phosphorylation in colorectal cancer. Cellular Signalling. 114. 110967–110967. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact